Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)

Sentiment:

SEC Form 4 Filing


The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.5651 per share on October 7, 2024, according to a Form 4 filing with the SEC.

Summary

  • On October 7, 2024, the W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock.
  • The sale price was $80.5651 per share.
  • Following the transaction, the W.K. Kellogg Foundation Trust beneficially owns 50,024,523 shares of Kellanova.
  • The sales were made pursuant to trading instructions given on May 7, 2024, intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction. The sale itself doesn't necessarily indicate a negative outlook, especially since it was pre-planned.

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency when corporate insiders and major shareholders trade their company's stock. This filing indicates a sale by a major shareholder, the W.K. Kellogg Foundation Trust.

Stakeholder Impact

  • The sale of shares by a major shareholder could potentially create short-term selling pressure on the stock.
  • However, the pre-planned nature of the sale may mitigate any significant negative impact.

Key Dates

DateDescription
August 30, 2017Date of Power of Attorney granted to Craig R. Carberry.
May 7, 2024Date of trading instructions given by the W.K. Kellogg Foundation Trust.
October 7, 2024Date of the transaction (sale of shares).

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.